Prime Medicine (PRME) PT Lowered to $6 at Citizens JMP
Tweet Send to a Friend
Citizens JMP analyst Silvan Tuerkcan lowered the price target on Prime Medicine (NASDAQ: PRME) to $6.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
